← Leaderboards
James A Cowan
Ohio State University
$1,758,887
Attributed
$1,758,887
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $435.2K · FY2005–10$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$1,758,887 · 3
By mechanism
R01$953,119 · 1
R21$805,768 · 2
Top collaborators
No co-investigators on record.
Most similar at Ohio State University
Same institution · by research overlap
- David G Jarjoura$3,458,851
- Dehua Pei$17,575,721
- Kristine E Yoder$6,387,948
- Martin F Sarter$13,437,306
- Joshua J Joseph$2,879,953
Others in their field
Top investigators on “Catalyst”
- Lee Marshall Nadler · Dana-Farber Cancer Inst$152,553,147
- Steven E Reis · University Of Pittsburgh At Pittsburgh$110,730,780
- Rebecca Montalvan · Westat, Inc.$86,600,000
- Mary L. Disis · University Of Washington$47,475,880
- Steven M. Dubinett · Va Greater Los Angeles Healthcare System$43,684,197
- Huw M Davies · Suny At Buffalo$43,386,311
Research focus
CatalystPrincipal InvestigatorDesignLeadOxidationPharmacologic SubstanceDrug DesignDrug ResistanceEvaluationKineticsMetalsBinding (Molecular Function)Oxidative DamagePeptidesMediatingDosageDrug DiscoveryProgramsEffectivenessEnzymesExperimental DesignsInvestigationMedicalProteins
Grant awards (8)
METALLOPEPTIDES AS THERAPEUTIC AGENTS$222,668
R21 · FY2010 · HL · contact PI
Novel Therapeutic Approaches to Pathogen Inactivation$212,500
R21 · FY2010 · AI · contact PI
Novel Therapeutic Approaches to Pathogen Inactivation$185,300
R21 · FY2009 · AI · contact PI
METALLOPEPTIDES AS THERAPEUTIC AGENTS$185,300
R21 · FY2009 · HL · contact PI
Novel Inorganic Nucleases$234,055
R01 · FY2006 · GM · contact PI
Novel Inorganic Nucleases$239,688
R01 · FY2005 · GM
Novel Inorganic Nucleases$239,688
R01 · FY2004 · GM
Novel Inorganic Nucleases$239,688
R01 · FY2003 · GM